Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Experimental Biology and Medicine (Maywood, N.J.)|October 29, 2021
Thioredoxin-mediated alteration of protein content and cytotoxicity of <i>Acinetobacter baumannii</i> outer membrane vesiclesSwathi Shrihari, Holly C May, Jieh-Juen Yu, et al.Frontiers in Microbiology|January 11, 2020
Thioredoxin Modulates Cell Surface Hydrophobicity in <i>Acinetobacter baumannii</i>Holly C May, Jieh-Juen Yu, Swathi Shrihari, et al.Biorxiv : the Preprint Server for Biology|March 10, 2021
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in miceJames Brett Case, Rita E Chen, Longxing Cao, et al.Cell Reports. Medicine|December 1, 2023
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protectionLucas J Adams, Laura A VanBlargan, Zhuoming Liu, et al.Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.Science Advances|August 23, 2024
CD4<sup>+</sup> and CD8<sup>+</sup> T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.Cell|July 16, 2020
The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling AxisEmma S Winkler, Swathi Shrihari, Barry L Hykes, et al.Biorxiv : the Preprint Server for Biology|July 18, 2020
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesisJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.Biorxiv : the Preprint Server for Biology|January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.Pageof 3